Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases have engineered the first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever.

Read More:
Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

Scroll to Top